ASTELLAS PHARMA INC./ JP3942400007 /
| 2024-11-07 9:44:20 PM | Chg. +0.065 | Volume | Bid2024-11-07 | Ask2024-11-07 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 10.490EUR | +0.62% | 93 Turnover: 971 |
10.355Bid Size: 240 | 10.500Ask Size: 240 | 18.94 bill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 9.51 JPY | -82.47% |
| EPS Diluted: | - JPY | -82.49% |
| Revenues per Share: | 881.13 JPY | 4.25% |
| Book Value per Share: | 876.91 JPY | 4.49% |
| Cash Flow per Share: | 94.77 JPY | -48.05% |
| Dividend per Share: | 70.00 JPY | 16.67% |
| Total | in mill. | |
| Revenues: | 1,603,672.00 JPY | 5.60% |
| Net Income: | 17,045.00 JPY | -82.73% |
| Operating Cash Flow: | 172,475.00 JPY | - |
| Cash and Cash Equivalents: | 335,687.00 JPY | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 182.39 | 172.82 |
| P/S Ratio: | 1.97 | 1.87 |
| P/BV ratio: | 1.98 | 1.87 |
| P/CF Ratio: | 18.30 | 17.34 |
| PEG: | -2.21 | -2.10 |
| Earnings Yield: | 0.55% | 0.58% |
| Dividend Yield: | 4.04% | 4.26% |
| Market Capitalization | ||
| Market Capitalization: | 18.94 bill. EUR | 19.14 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 1.82 bill. | |
Profitability
| Gross Profit Margin: | 81.76% |
| EBIT Margin: | 1.59% |
| Net Profit Margin: | 1.06% |
| Return on Equity: | 1.07% |
| Return on Assets: | 0.48% |
Financial Strength
| Liquidity I / Cash Ratio: | 26.11% |
| Liquidity II / Quick Ratio: | 69.28% |
| Liquidity III / Current Ratio: | 92.92% |
| Debt / Equity Ratio: | 123.66% |
| Dynam. Debt / Equity Ratio: | 1,144.29% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - JPY |
| Revenues / Employee: | - JPY |
| Net Income / Employee: | - JPY |
| Total Assets / Employee: | - JPY |
| * Fiscal Year End: | 2024-03-31 |
| Accounting Standard: | IFRS |
| Currency: | JPY |
